STAT Plus: Pharmalittle: Regeneron Covid-19 antibody treatment works in animals; Warren asks SEC to probe Kodak trading
Top of the morning to you, and a fine one it is. Despite a looming tropical storm and gloomy skies hovering over the Pharmalot campus, our spirits are sunny today. And why not? As the Morning Mayor taught us: Every day should be unwrapped like a precious gift. We often note this little insight, because a pick-me-up can be a good thing, especially in times such as these. Meanwhile, here are a few items of interest to help you start your day. Hope all goes well and do stay in touch. Remember, we accept saucy tips and dossiers. …
Regeneron Pharmaceuticals (REGN) says its Covid-19 antibody drug combination prevented and treated the virus in rhesus macaques and hamsters, Reuters writes. The animal study, which has not yet been peer-reviewed, found the cocktail of two monoclonal antibodies was able to “almost completely block establishment of virus infection.” The cocktail also minimized infection in a second study in which animals were infected with a higher level of the virus, but the prophylactic effect was greatly diminished with a lower dose.
Continue to STAT Plus to read the full story…
